Evidence for proangiogenic cellular and humoral systemic response in patients with acute onset of spinal cord injury

References

• Mautes AE, Weinzierl MR, Donovan F, Noble LJ. Vascular events after spinal cord injury: contribution to secondary pathogenesis. Phys Ther 2000;80(7):673–87.
   PubMed Web of Science ®Google Scholar
• Graumann U, Ritz MF, Hausmann O. Necessity for re-vascularization after spinal cord injury and the search for potential therapeutic options. Curr Neurovasc Res 2011;8(4):334–41.
   PubMed Web of Science ®Google Scholar
• Herrera JJ, Sundberg LM, Zentilin L, Giacca M, Narayana PA. Sustained expression of vascular endothelial growth factor and angiopoietin-1 improves blood-spinal cord barrier integrity and functional recovery after spinal cord injury. J Neurotrauma 2010;27(11):2067–76.
   PubMed Web of Science ®Google Scholar
• Kamei N, Kwon SM, Ishikawa M, Ii M, Nakanishi K, Yamada K, et al. Endothelial progenitor cells promote astrogliosis following spinal cord injury through Jagged1-dependent Notch signaling. J Neurotrauma 2012;29(9):1758–69.
   PubMed Web of Science ®Google Scholar
• Ng MT, Stammers AT, Kwon BK. Vascular disruption and the role of angiogenic proteins after spinal cord injury. Transl Stroke Res 2011;2(4):474–91.
   PubMed Web of Science ®Google Scholar
• Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999;18(14):3964–72.
   PubMed Web of Science ®Google Scholar
• Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000;95(3):952–8.
   PubMed Web of Science ®Google Scholar
• Friedrich EB, Walenta K, Scharlau J, Nickenig G, Werner N. CD34-/CD133+/VEGFR-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities. Circ Res 2006;98(3):e20–5.
   PubMed Web of Science ®Google Scholar
• Massa M, Rosti V, Ferrario M, Campanelli R, Ramajoli I, Rosso R, et al. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 2005;105(1):199–206.
   PubMed Web of Science ®Google Scholar
• Erdbruegger U, Haubitz M, Woywodt A. Circulating endothelial cells: a novel marker of endothelial damage. Clin Chim Acta 2006;373(1–2):17–26.
   PubMed Web of Science ®Google Scholar
• Nakamura T, Mizuno S. The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine. Proc Jpn Acad B Phys Biol Sci 2010;86(6):588–610.
   PubMed Web of Science ®Google Scholar
• Ponte AL, Marais E, Gallay N, Langonné A, Delorme B, Hérault O, et al. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 2007;25(7):1737–45.
   PubMed Web of Science ®Google Scholar
• Ritz MF, Graumann U, Gutierrez B, Hausmann O. Traumatic spinal cord injury alters angiogenic factors and TGF-beta1 that may affect vascular recovery. Curr Neurovasc Res 2010;7(4):301–10.
   PubMed Web of Science ®Google Scholar
• Spinella F, Rosanò L, Del, Duca M, Di, Castro V, Nicotra MR, Natali PG, et al. Endothelin-1 inhibits prolyl hydroxylase domain 2 to activate hypoxia-inducible factor-1alpha in melanoma cells. PLoS ONE 2010;5(6):e11241.
   PubMedGoogle Scholar
• Ohkita M, Tawa M, Kitada K, Matsumura Y. Pathophysiological roles of endothelin receptors in cardiovascular diseases. J Pharmacol Sci 2012;119(4):302–13.
   PubMed Web of Science ®Google Scholar
• Kermani P, Hempstead B. Brain-derived neurotrophic factor: a newly described mediator of angiogenesis. Trends Cardiovasc Med 2007;17(4):140–3.
   PubMed Web of Science ®Google Scholar
• Schulte-Herbrüggen O, Nassenstein C, Lommatzsch M, Quarcoo D, Renz H, Braun A. Tumor necrosis factor-alpha and interleukin-6 regulate secretion of brain-derived neurotrophic factor in human monocytes. J Neuroimmunol 2005;160(1–2):204–9.
   PubMed Web of Science ®Google Scholar
• Paczkowska E, Kaczynska K, Pius-Sadowska E, Roginska D, Kawa M, Ustianowski P, et al. Humoral activity of cord blood-derived stem/progenitor cells: implications for stem cell-based adjuvant therapy of neurodegenerative disorders. PLoS ONE 2013;8(12):e83833.
   PubMedGoogle Scholar
• Fassbender JM, Whittemore SR, Hagg T. Targeting microvasculature for neuroprotection after SCI. Neurotherapeutics 2011;8(2):240–51.
   PubMed Web of Science ®Google Scholar
• Paczkowska E, Gołąb-Janowska M, Bajer-Czajkowska A, Machalińska A, Ustianowski P, Rybicka M, et al. Increased circulating endothelial progenitor cells in patients with haemorrhagic and ischaemic stroke: the role of endothelin-1. J Neurol Sci 2013;325(1–2):90–9.
   PubMed Web of Science ®Google Scholar
• Sasaki H, Ishikawa M, Tanaka N, Nakanishi K, Kamei N, Asahara T, et al. Administration of human peripheral blood-derived CD133+ cells accelerates functional recovery in a rat spinal cord injury model. Spine (Phila Pa 1976) 2009;34(3):249–54.
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Natsume A, Wakabayashi T, Aoshima C, Shimato S, Ito M, et al. Intravenously transplanted human neural stem cells migrate to the injured spinal cord in adult mice in an SDF-1- and HGF-dependent manner. Neurosci Lett 2007;426(2):69–74.
   PubMed Web of Science ®Google Scholar
• Van Belle E, Witzenbichler B, Chen D, Silver M, Chang L, Schwall R, et al. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation 1998;97(4):381–90.
   PubMed Web of Science ®Google Scholar
• Jalili A, Shirvaikar N, Marquez-Curtis LA, Turner AR, Janowska-Wieczorek A. The HGF/c-Met axis synergizes with G-CSF in the mobilization of hematopoietic stem/progenitor cells. Stem Cells Dev 2010;19(8):1143–51.
   PubMed Web of Science ®Google Scholar
• Kitamura K, Iwanami A, Nakamura M, Yamane J, Watanabe K, Suzuki Y, et al. Hepatocyte growth factor promotes endogenous repair and functional recovery after spinal cord injury. J Neurosci Res 2007;85(11):2332–42.
   PubMed Web of Science ®Google Scholar
• Date I, Takagi N, Takagi K, Kago T, Matsumoto K, Nakamura T, et al. Hepatocyte growth factor attenuates cerebral ischemia-induced learning dysfunction. Biochem Biophys Res Commun 2004;319(4):1152–8.
   PubMed Web of Science ®Google Scholar
• Masjkur J, Rueger MA, Bornstein SR, McKay R, Androutsellis-Theotokis A. Neurovascular signals suggest a propagation mechanism for endogenous stem cell activation along blood vessels. CNS Neurol Disord Drug Targets 2012;11(7):805–17.
   PubMed Web of Science ®Google Scholar
• Durham-Lee JC, Wu Y, Mokkapati VU, Paulucci-Holthauzen AA, Nesic O. Induction of angiopoietin-2 after spinal cord injury. Neuroscience 2012;202:454–64.
   PubMed Web of Science ®Google Scholar
• Daly C, Pasnikowski E, Burova E, Wong V, Aldrich TH, Griffiths J, et al. Angiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells. Proc Natl Acad Sci USA 2006;103(42):15491–6.
   PubMed Web of Science ®Google Scholar
• Ahn YH, Bae YY, Lee G, Kang MK, Kang SK. Molecular insights of the injured lesions of rat spinal cords: inflammation, apoptosis, and cell survival. Biochem Biophys Res Comm 2006;348(2):560–70.
   PubMed Web of Science ®Google Scholar
• Kang MK, Kang SK. Interleukin-6 induces proliferation in adult spinal cord-derived neural progenitors via the JAK2/STAT3 pathway with EGF-induced MAPK phosphorylation. Cell Prolif 2008;41(3):377–92.
   PubMed Web of Science ®Google Scholar
• Gaál EI, Tammela T, Anisimov A, Marbacher S, Honkanen P, Zarkada G, et al. Comparison of vascular growth factors in the murine brain reveals placenta growth factor as prime candidate for CNS revascularization. Blood 2013;122(5):658–65.
   PubMed Web of Science ®Google Scholar
• Seghers L, de Vries MR, Pardali E, Hoefer IE, Hierck BP, ten Dijke P, et al. Shear induced collateral artery growth modulated by endoglin but not by ALK1. J Cell Mol Med 2012;16(10):2440–50.
   PubMed Web of Science ®Google Scholar
• Kapur NK, Morine KJ, Letarte M. Endoglin: a critical mediator of cardiovascular health. Vasc Health Risk Manag 2013;9:195–206.
   PubMedGoogle Scholar
• Tyor WR, Avgeropoulos N, Ohlandt G, Hogan EL. Treatment of spinal cord impact injury in the rat with transforming growth factor-beta. J Neurol Sci 2002;200(1–2):33–41.
   PubMed Web of Science ®Google Scholar
• Böhm F, Pernow J. The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. Cardiovasc Res 2007;76(1):8–18.
   PubMed Web of Science ®Google Scholar
• Zimmermann M, Seifert V. Endothelin and subarachnoid hemorrhage: an overview. Neurosurgery 1998;43(4):863–75.
   PubMed Web of Science ®Google Scholar
• Rogers SD, Peters CM, Pomonis JD, Hagiwara H, Ghilardi JR, Mantyh PW. Endothelin B receptors are expressed by astrocytes and regulate astrocyte hypertrophy in the normal and injured CNS. Glia 2003;41(2):180–90.
   PubMed Web of Science ®Google Scholar
• Hama H, Sakurai T, Kasuya Y, Fujiki M, Masaki T, Goto K. Action of endothelin-1 on rat astrocytes through the ETB receptor. Biochem Biophys Res Commun 1992;186(1):355–62.
   PubMed Web of Science ®Google Scholar
• Uesugi M, Kasuya Y, Hama H, Yamamoto M, Hayashi K, Masaki T, et al. Endogenous endothelin-1 initiates astrocytic growth after spinal cord injury. Brain Res 1996;728(2):255–9.
   PubMed Web of Science ®Google Scholar
• Salzman SK, Acosta R, Beck G, Madden J, Boxer B, Ohlstein EH. Spinal endothelin content is elevated after moderate local trauma in the rat to levels associated with locomotor dysfunction after intrathecal injection. J Neurotrauma 1996;13(2):93–101.
   PubMed Web of Science ®Google Scholar
• Westmark R, Noble LJ, Fukuda K, Aihara N, McKenzie AL. Intrathecal administration of endothelin-1 in the rat: impact on spinal cord blood flow and the blood-spinal cord barrier. Neurosci Lett 1995;192(3):173–6.
   PubMed Web of Science ®Google Scholar
• Yamada G, Hama H, Kasuya Y, Masaki T, Goto K. Possible sources of endothelin-1 in damaged rat brain. J Cardiovasc Pharmacol 1995;26 (Suppl 3):S486–90.
   PubMedGoogle Scholar
• Wang TD, Wang YH, Huang TS, Su TC, Pan SL, Chen SY. Circulating levels of markers of inflammation and endothelial activation are increased in men with chronic spinal cord injury. J Formos Med Assoc 2007;106(11):919–28.
   PubMed Web of Science ®Google Scholar
• Galié N, Manes A, Branzi A. The endothelin system in pulmonary arterial hypertension. Cardiovasc Res 2004;61(2):227–37
   PubMed Web of Science ®Google Scholar
• Onuoha GN, Alpar EK. Calcitonin gene-related peptide and other neuropeptides in the plasma of patients with soft tissue injury. Life Sci 1999;65(13):1351–8.
   PubMed Web of Science ®Google Scholar
• Furlan JC, Fehlings MG. Cardiovascular complications after acute spinal cord injury: pathophysiology, diagnosis, and management. Neurosurg Focus 2008;25(5):E13.
   PubMed Web of Science ®Google Scholar
• Namiki J, Kojima A, Tator CH. Effect of brain-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 on functional recovery and regeneration after spinal cord injury in adult rats. J Neurotrauma 2000;17(12):1219–31.
   PubMed Web of Science ®Google Scholar
• Rosner J, Avalos P, Acosta F, Liu J, Drazin D. The potential for cellular therapy combined with growth factors in spinal cord injury. Stem Cells Int 2012;2012:826754.
   PubMedGoogle Scholar
• Vavrek R, Girgis J, Tetzlaff W, Hiebert GW, Fouad K. BDNF promotes connections of corticospinal neurons onto spared descending interneurons in spinal cord injured rats. Brain 2006;129(Pt 6):1534–45.
   PubMed Web of Science ®Google Scholar
• Karege F, Schwald M, Cisse M. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett 2002;328(3):261–4.
   PubMed Web of Science ®Google Scholar
• Kapczinski F, Frey BN, Kauer-Sant'Anna M, Grassi-Oliveira R. Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder. Expert Rev Neurother 2008;8(7):1101–13.
   PubMedGoogle Scholar
• Poduslo JF, Curran GL. Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF. Brain Res Mol Brain Res 1996;36(2):280–6.
   PubMedGoogle Scholar
• Schaaf MJ, Duurland R, de Kloet ER, Vreugdenhil E. Circadian variation in BDNF mRNA expression in the rat hippocampus. Brain Res Mol Brain Res 2000;75(2):342–4.
   PubMedGoogle Scholar
• Stirling DP, Yong VW. Dynamics of the inflammatory response after murine spinal cord injury revealed by flow cytometry. J Neurosci Res 2008;86(9):1944–58.
   PubMed Web of Science ®Google Scholar
• Chamankhah M, Eftekharpour E, Karimi-Abdolrezaee S, Boutros PC, San-Marina S, Fehlings MG. Genome-wide gene expression profiling of stress response in a spinal cord clip compression injury model. BMC Genomics 2013;14(1):583.
   PubMed Web of Science ®Google Scholar